In line with this notion, pharmacological inhibition of NCX revealed a strong reduction in ischemia-induced intracellular Ca2+ levels in neurons during ischemia, and PIDs, in particular, and should therefore lead to a better outcome (Gerkau et al., 2018). The gene discussed is TLX2; the disease is ischemia.